Literature DB >> 1771741

Enterovirulence of enterotoxigenic Bacteroides fragilis in gnotobiotic pigs.

J R Duimstra1, L L Myers, J E Collins, D A Benfield, D S Shoop, W C Bradbury.   

Abstract

A porcine isolate of enterotoxigenic Bacteroides fragilis colonized the intestinal tract and caused watery, nonhemorrhagic diarrhea when given orally to 12, 1- to 2-day-old gnotobiotic pigs. Diarrhea occurred 2 to 3 days post-inoculation and continued throughout the 4 to 6 day post-inoculation period. Diarrheic pigs became mildly anorexic and dehydrated. They developed intestinal lesions characterized by swelling, vacuolation, and exfoliation of enterocytes, and crypt hyperplasia throughout the large intestine and, to a lesser extent, in the distal small intestine. Bacterial adherence to, or invasion of, the intestinal mucosa was not detected. A porcine isolate of nonenterotoxigenic B. fragilis was administered orally to six control pigs. The isolate colonized the intestinal tract, but the pigs did not develop clinical disease or intestinal lesions. The pathogenetic mechanism of the disease may involve mediation by a soluble enterotoxin (or toxins) elaborated by B. fragilis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1771741     DOI: 10.1177/030098589102800608

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  12 in total

1.  Monoclonal antibodies to the enterotoxin of Bacteroides fragilis: production, characterization, and immunodiagnostic application.

Authors:  F Qadri; M G Mohi; A Chowdhury; K Alam; T Azim; C Sears; R B Sack; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

2.  Evaluation of the pathogenicity of the Bacteroides fragilis toxin gene subtypes in gnotobiotic mice.

Authors:  Viviane Nakano; Danielle A Gomes; Rosa M E Arantes; Jacques R Nicoli; Mario J Avila-Campos
Journal:  Curr Microbiol       Date:  2006-07-10       Impact factor: 2.188

3.  Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro.

Authors:  M Riegler; M Lotz; C Sears; C Pothoulakis; I Castagliuolo; C C Wang; R Sedivy; T Sogukoglu; E Cosentini; G Bischof; W Feil; B Teleky; G Hamilton; J T LaMont; E Wenzl
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

4.  Human intestinal epithelial cells swell and demonstrate actin rearrangement in response to the metalloprotease toxin of Bacteroides fragilis.

Authors:  S S Koshy; M H Montrose; C L Sears
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  The enterotoxin of Bacteroides fragilis is a metalloprotease.

Authors:  J S Moncrief; R Obiso; L A Barroso; J J Kling; R L Wright; R L Van Tassell; D M Lyerly; T D Wilkins
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid secretion and intestinal damage in vivo.

Authors:  R J Obiso; D M Lyerly; R L Van Tassell; T D Wilkins
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea.

Authors:  Cynthia L Sears; Salequl Islam; Amit Saha; Maleka Arjumand; Nur Haque Alam; A S G Faruque; M A Salam; Jai Shin; David Hecht; Andrej Weintraub; R Bradley Sack; Firdausi Qadri
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

8.  Salmonella enterica Serovar Typhimurium Temporally Modulates the Enteric Microbiota and Host Responses To Overcome Colonization Resistance in Swine.

Authors:  Danisa M Bescucci; Paul E Moote; Rodrigo Ortega Polo; Richard R E Uwiera; G Douglas Inglis
Journal:  Appl Environ Microbiol       Date:  2020-10-15       Impact factor: 4.792

9.  Characterization of enterotoxigenic Bacteroides fragilis by a toxin-specific enzyme-linked immunosorbent assay.

Authors:  R L Van Tassell; D M Lyerly; T D Wilkins
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

Review 10.  Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes.

Authors:  Cynthia L Sears
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.